These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27739361)

  • 61. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nanomedicine and drug delivery systems in cancer and regenerative medicine.
    Garbayo E; Pascual-Gil S; Rodríguez-Nogales C; Saludas L; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1637. PubMed ID: 32351045
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exploiting Enzyme Alterations in Cancer for Drug Activation, Drug Delivery, and Nanotherapy.
    Hayashi JY; Tamanoi F
    Enzymes; 2017; 42():153-172. PubMed ID: 29054269
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anticancer drugs in liposomal nanodevices: a target delivery for a targeted therapy.
    Urbinati G; Marsaud V; Renoir JM
    Curr Top Med Chem; 2012; 12(15):1693-712. PubMed ID: 22978336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Nanostructured liposomal systems as transport agents for anticancer drugs].
    Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 2012; (3):23-31. PubMed ID: 22712271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug delivery systems improving chemical and physical properties of anticancer drugs currently investigated for treatment of solid tumors.
    Aleksandrowicz R; Taciak B; Krol M
    J Physiol Pharmacol; 2017 Apr; 68(2):165-174. PubMed ID: 28614765
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
    Zhang E; Zhang C; Su Y; Cheng T; Shi C
    Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
    Gao W; Xiang B; Meng TT; Liu F; Qi XR
    Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multifunctional nanomicellar systems for delivering anticancer drugs.
    Chen YC; Lo CL; Hsiue GH
    J Biomed Mater Res A; 2014 Jun; 102(6):2024-38. PubMed ID: 23828850
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
    Sharma AK; Gothwal A; Kesharwani P; Alsaab H; Iyer AK; Gupta U
    Drug Discov Today; 2017 Feb; 22(2):314-326. PubMed ID: 27671487
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency.
    Kim SW; Khang D
    Int J Nanomedicine; 2015; 10():3989-4008. PubMed ID: 26124658
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Microfluidics: a focus on improved cancer targeted drug delivery systems.
    Khan IU; Serra CA; Anton N; Vandamme T
    J Control Release; 2013 Dec; 172(3):1065-74. PubMed ID: 23933524
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Physical mechanisms and methods employed in drug delivery to tumors.
    Besić E
    Acta Pharm; 2007 Sep; 57(3):249-68. PubMed ID: 17878107
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Photoacoustic "nanobombs" fight against undesirable vesicular compartmentalization of anticancer drugs.
    Chen A; Xu C; Li M; Zhang H; Wang D; Xia M; Meng G; Kang B; Chen H; Wei J
    Sci Rep; 2015 Oct; 5():15527. PubMed ID: 26483341
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery.
    Li Y; Du L; Wu C; Yu B; Zhang H; An F
    Curr Top Med Chem; 2019; 19(1):74-97. PubMed ID: 30686257
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumour-specific uptake of anti-cancer drugs: the future is here.
    Caraglia M; Marra M; Misso G; Lamberti M; Salzano G; De Rosa G; Abbruzzese A
    Curr Drug Metab; 2012 Jan; 13(1):4-21. PubMed ID: 22292808
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drug penetration in solid tumours.
    Minchinton AI; Tannock IF
    Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.